Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

Background: Ovarian cancer (OC) is the second most common gynecological malignancy and has a high mortality rate. The current chemotherapeutic drugs have the disadvantages of drug resistance and side effects. Myricetin, a kind of natural compound, has the advantages of easy extraction, low price, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui-Wen, Lan, Yan, Li, An, Wu, Han, Song, Zi-Wei, Wan, Ai-Ling, Wang, Yue, Li, Shi-Bao, Ji, Shuai, Wang, Zhong-Cheng, Wu, Xin-Yu, Lan, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665490/
https://www.ncbi.nlm.nih.gov/pubmed/38026996
http://dx.doi.org/10.3389/fphar.2023.1288883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665490/
https://www.ncbi.nlm.nih.gov/pubmed/38026996
http://dx.doi.org/10.3389/fphar.2023.1288883

Ejemplares similares